{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:24:04Z","timestamp":1793431444640,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ebiom.2021.103291","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T03:02:22Z","timestamp":1617332542000},"page":"103291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-5175","authenticated-orcid":false,"given":"Martin S.","family":"Winkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Skirecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Cavaillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie B.","family":"Floh\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Garc\u00eda-Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Girardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Kox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Spinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg C.","family":"Schefold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Uhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Scherag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-9883","authenticated-orcid":false,"given":"Marcin F.","family":"Osuchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ebiom.2021.103291_bib0001","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/j.cub.2020.10.033","article-title":"How the COVID-19 pandemic highlights the necessity of animal research","volume":"30","author":"Genzel","year":"2020","journal-title":"Curr Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0002","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/SHK.0000000000001565","article-title":"SARS-CoV-2\/COVID-19: Evolving reality, global response, knowledge gaps, and opportunities","volume":"54","author":"Osuchowski","year":"2020","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40635-020-00312-4","article-title":"Research Committee of the Surviving Sepsis C. the surviving sepsis campaign: basic\/translational science research priorities","volume":"8","author":"Deutschman","year":"2020","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40635-020-00304-4","article-title":"Translational Biology G. the importance of discovery science in the development of therapies for the critically ill","volume":"8","author":"Juffermans","year":"2020","journal-title":"Intensive Care Med Exp"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103291_bib0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Munoz-Fontela","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s13054-020-03304-8","article-title":"Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review","volume":"24","author":"Ehaideb","year":"2020","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0007","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A Mouse-Adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"issue":"6511","key":"10.1016\/j.ebiom.2021.103291_bib0008","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103291_bib0009","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0010","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201241","article-title":"Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling","volume":"217","author":"Israelow","year":"2020","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0012","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"issue":"7818","key":"10.1016\/j.ebiom.2021.103291_bib0013","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","article-title":"Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2","volume":"182","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0016","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","article-title":"Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment","volume":"182","author":"Sun","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0017","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 Infection model in mice demonstrates protection by neutralizing antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"issue":"6518","key":"10.1016\/j.ebiom.2021.103291_bib0018","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0019","first-page":"4221","article-title":"Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19","volume":"22","author":"Davies","year":"2020","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res"},{"issue":"23","key":"10.1016\/j.ebiom.2021.103291_bib0021","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.23.2001005","article-title":"SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020","volume":"25","author":"Oreshkova","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ebiom.2021.103291_bib0022","article-title":"SARS-CoV-2 and the human-animal interface: outbreaks on mink farms","author":"Koopmans","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0023","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/s41598-020-72563-w","article-title":"Susceptibility of tree shrew to SARS-CoV-2 infection","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0024","doi-asserted-by":"crossref","first-page":"517","DOI":"10.24272\/j.issn.2095-8137.2020.053","article-title":"COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2","volume":"41","author":"Xu","year":"2020","journal-title":"Zool Res"},{"issue":"6494","key":"10.1016\/j.ebiom.2021.103291_bib0025","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0026","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMc2013400","article-title":"Transmission of SARS-CoV-2 in Domestic Cats","volume":"383","author":"Halfmann","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/22221751.2020.1868951","article-title":"Susceptibility of rabbits to SARS-CoV-2","volume":"10","author":"Mykytyn","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0028","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S2666-5247(20)30089-6","article-title":"SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study","volume":"1","author":"Schlottau","year":"2020","journal-title":"Lancet Microbe"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0029","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3201\/eid2612.202989","article-title":"Lack of susceptibility to SARS-CoV-2 and MERS-CoV in Poultry","volume":"26","author":"Suarez","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"28","key":"10.1016\/j.ebiom.2021.103291_bib0030","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","article-title":"Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development","volume":"117","author":"Imai","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0031","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1038\/s41467-020-19684-y","article-title":"STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters","volume":"11","author":"Boudewijns","year":"2020","journal-title":"Nat Commun"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103291_bib0032","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ame2.12108","article-title":"Age-related rhesus macaque models of COVID-19","volume":"3","author":"Yu","year":"2020","journal-title":"Animal Model Exp Med"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0034","doi-asserted-by":"crossref","first-page":"503","DOI":"10.24272\/j.issn.2095-8137.2020.202","article-title":"Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques","volume":"41","author":"Song","year":"2020","journal-title":"Zool Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41564-020-00841-4","article-title":"Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets","volume":"6","author":"Singh","year":"2021","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103291_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/v12070779","article-title":"Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters","volume":"12","author":"Osterrieder","year":"2020","journal-title":"Viruses"},{"issue":"7843","key":"10.1016\/j.ebiom.2021.103291_bib0037","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","article-title":"COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice","volume":"589","author":"Zheng","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01114-20","article-title":"Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets","volume":"11","author":"Park","year":"2020","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0039","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","article-title":"Infection and Rapid Transmission of SARS-CoV-2 in Ferrets","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0040","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/s41467-020-17367-2","article-title":"SARS-CoV-2 is transmitted via contact and via the air between ferrets","volume":"11","author":"Richard","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0041","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009195","article-title":"K18-hACE2 mice develop respiratory disease resembling severe COVID-19","volume":"17","author":"Yinda","year":"2021","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0043","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103291_bib0044","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","article-title":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"198","author":"Channappanavar","year":"2017","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02786829308959603","article-title":"Lower respiratory tract structure of laboratory animals and humans: dosimetry implications","volume":"18","author":"Miller","year":"1993","journal-title":"Aerosol Science and Technology"},{"key":"10.1016\/j.ebiom.2021.103291_bib0046","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semcdb.2019.11.006","article-title":"Lung regeneration: a tale of mice and men","volume":"100","author":"Basil","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0047","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1165\/ajrcmb\/3.2.131","article-title":"Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?","volume":"3","author":"Pabst","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0048","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/CCM.0b013e3181b9ed2e","article-title":"Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice","volume":"38","author":"Baumgart","year":"2010","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0049","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41392-020-0176-0","article-title":"Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2021.103291_bib0050","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","author":"White","year":"2021","journal-title":"Science"},{"issue":"7826","key":"10.1016\/j.ebiom.2021.103291_bib0051","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.ebiom.2021.103291_bib0052","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity","volume":"117","author":"Kaptein","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7824","key":"10.1016\/j.ebiom.2021.103291_bib0053","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0054","article-title":"Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models","author":"Li","year":"2021","journal-title":"J Med Chem"},{"issue":"6506","key":"10.1016\/j.ebiom.2021.103291_bib0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.ebiom.2021.103291_bib0056","article-title":"An Antioxidant Enzyme Therapeutic for COVID-19","volume":"32","author":"Qin","year":"2020","journal-title":"Adv Mater"},{"issue":"6499","key":"10.1016\/j.ebiom.2021.103291_bib0057","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103291_bib0058","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103291_bib0059","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.ebiom.2021.103291_bib0060","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0061","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103291_bib0062","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014468117","article-title":"A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine","author":"Horner","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2021.103291_bib0063","article-title":"Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters","author":"Jia","year":"2020","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0064","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","article-title":"Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"22","key":"10.1016\/j.ebiom.2021.103291_bib0065","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0066","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"issue":"10169","key":"10.1016\/j.ebiom.2021.103291_bib0067","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103291_bib0068","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0069","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2021.103291_bib0070","first-page":"45","article-title":"Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials","author":"Deb","year":"2020","journal-title":"J Biosci"},{"key":"10.1016\/j.ebiom.2021.103291_bib0071","first-page":"579","article-title":"Don't rush to deploy COVID-19 vaccines and drugs","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0072","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103291_bib0073","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103291_bib0074","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103291_bib0075","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of Hydrocortisone on 21-day mortality or respiratory support among critically Ill patients with COVID-19: a randomized clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0076","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S2213-2600(20)30503-8","article-title":"Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties","volume":"8","author":"Matthay","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0077","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1172\/JCI143331","article-title":"Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome","volume":"130","author":"Matthay","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103291_bib0078","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in Sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0079","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01009-2020","article-title":"Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective","volume":"55","author":"Halpin","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103291_bib0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S2213-2600(20)30314-3","article-title":"Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?","volume":"8","author":"Nicolau","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2021.103291_bib0081","first-page":"1","article-title":"Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?","author":"Rogliani","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0082","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113406","article-title":"Inhaled Corticosteroids and COVID-19 risk and mortality: a nationwide cohort study","volume":"9","author":"Choi","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0083","article-title":"Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients","volume":"1","author":"Bonam","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2021.103291_bib0084","doi-asserted-by":"crossref","first-page":"m4530","DOI":"10.1136\/bmj.m4530","article-title":"Covid-19: Critically ill patients treated with arthritis drug tocilizumab show improved outcomes, researchers report","volume":"371","author":"Wise","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103291_bib0085","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ebiom.2021.103291_bib0086","article-title":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial","author":"group","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0087","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103291_bib0088","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41577-020-0357-7","article-title":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches","volume":"20","author":"Lang","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2021.103291_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial","author":"Feld","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0091","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) Mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0092","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0093","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-020-00286-5","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial","volume":"5","author":"Meng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2021.103291_bib0094","article-title":"The COVID-19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections","author":"Vaja","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2021.103291_bib0095","article-title":"Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes","volume":"133","author":"Kelleni","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0096","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s13063-020-04696-2","article-title":"The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng\/kg\/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Johansson","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ebiom.2021.103291_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0098","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1186\/s13063-020-04884-0","article-title":"Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Declercq","year":"2020","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0099","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0100","first-page":"e0280","article-title":"Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019","volume":"2","author":"Sakoulas","year":"2020","journal-title":"Crit Care Explor"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s13063-020-04501-0","article-title":"CytoResc - \"CytoSorb\" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Stockmann","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ebiom.2021.103291_bib0102","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","author":"Barnes","year":"2020","journal-title":"Nature"},{"issue":"7815","key":"10.1016\/j.ebiom.2021.103291_bib0103","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0104","first-page":"205","article-title":"COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19","volume":"3","author":"Yang","year":"2020","journal-title":"Antib Ther"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103291_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0106","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19","author":"Chen","year":"2020","journal-title":"N Engl J Med"},{"issue":"6490","key":"10.1016\/j.ebiom.2021.103291_bib0107","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.abc1731","article-title":"Against pandemic research exceptionalism","volume":"368","author":"London","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103291_bib0108","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"4 Suppl","key":"10.1016\/j.ebiom.2021.103291_bib0109","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/CCM.0b013e3181cbaff4","article-title":"Clinical research ethics for critically ill patients: a pandemic proposal","volume":"38","author":"Cook","year":"2010","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-016-0760-x","article-title":"Modernising epidemic science: enabling patient-centred research during epidemics","volume":"14","author":"Rojek","year":"2016","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103291_bib0111","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103291_bib0112","article-title":"Scientific Rigor in the Age of COVID-19","author":"Shyr","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ebiom.2021.103291_bib0113","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejim.2020.06.006","article-title":"Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era","volume":"77","author":"Rossi","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ebiom.2021.103291_bib0114","article-title":"Direct oral anticoagulant use and risk of severe COVID-19","author":"Flam","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.ebiom.2021.103291_bib0115","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3389\/fimmu.2018.02507","article-title":"Commentary: arguing for adaptive clinical trials in sepsis","volume":"9","author":"Kesselmeier","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0116","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/SHK.0000000000001164","article-title":"Premise for standardized sepsis models","volume":"51","author":"Remick","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0000000000001243","article-title":"Part I: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for study design and humane modeling endpoints","volume":"51","author":"Zingarelli","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2020.1839959","article-title":"Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019","volume":"53","author":"Bansal","year":"2021","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0119","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s13063-020-04711-6","article-title":"It is unprecedented: trial management during the COVID-19 pandemic and beyond","volume":"21","author":"Mitchell","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ebiom.2021.103291_bib0120","series-title":"The ethics of COVID-19 treatment studies: too many are open, too few are double-masked","author":"Aronson","year":"2020"},{"key":"10.1016\/j.ebiom.2021.103291_bib0121","first-page":"1742","volume":"20","author":"Yanez","year":"2020"},{"key":"10.1016\/j.ebiom.2021.103291_bib0122","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3389\/fimmu.2017.01806","article-title":"Differential susceptibility to infectious respiratory diseases between males and females linked to sex-specific innate immune inflammatory response","volume":"8","author":"Chamekh","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0123","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000363300","article-title":"Recent advances in animal models of diabetic nephropathy","volume":"126","author":"Betz","year":"2014","journal-title":"Nephron Exp Nephrol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0124","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1750-2659.2012.00414.x","article-title":"Influenza A H1N1 induces declines in alveolar gas exchange in mice consistent with rapid post-infection progression from acute lung injury to ARDS","volume":"7","author":"Traylor","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2009.05.004","article-title":"Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection","volume":"390","author":"Verhoeven","year":"2009","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13613-019-0543-6","article-title":"Preclinical septic shock research: why we need an animal ICU","volume":"9","author":"Guillon","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0127","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40635-018-0189-y","article-title":"Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis","volume":"6","author":"Osuchowski","year":"2018","journal-title":"Intensive Care Med Exp"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0128","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/CCM.0b013e31819df06b","article-title":"Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis","volume":"37","author":"Osuchowski","year":"2009","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1750-2659.2011.00254.x","article-title":"Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus","volume":"5","author":"Easterbrook","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173008","article-title":"Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection","volume":"12","author":"Kawaguchi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2021.103291_bib0131","article-title":"Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsis","author":"Efron","year":"2020","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103291_bib0132","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.celrep.2019.07.028","article-title":"Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization","volume":"28","author":"Huggins","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0133","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1189\/jlb.5MR0315-127R","article-title":"The future of murine sepsis and trauma research models","volume":"98","author":"Efron","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0134","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.shk.0000235130.82363.ed","article-title":"Pneumonia after cecal ligation and puncture: a clinically relevant \"two-hit\" model of sepsis","volume":"26","author":"Muenzer","year":"2006","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0135","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jiz692","article-title":"Trained immunity confers broad-spectrum protection against bacterial infections","volume":"222","author":"Ciarlo","year":"2020","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0136","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 Infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.ebiom.2021.103291_bib0137","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1001\/jama.296.14.1731","article-title":"Translation of research evidence from animals to humans","volume":"296","author":"Hackam","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0138","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/SHK.0000000000000153","article-title":"Abandon the mouse research ship?","volume":"41","author":"Osuchowski","year":"2014","journal-title":"Not just yet! Shock"},{"issue":"21","key":"10.1016\/j.ebiom.2021.103291_bib0139","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0300-9572(96)01055-6","volume":"33","author":"Idris","year":"1996","journal-title":"Resuscitation"},{"key":"10.1016\/j.ebiom.2021.103291_bib0141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.08.108","article-title":"Animal models for diabetes: understanding the pathogenesis and finding new treatments","volume":"99","author":"King","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103291_bib0142","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nri1502","article-title":"Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes","volume":"4","author":"Roep","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103291_bib0143","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/STROKEAHA.116.013643","article-title":"Reporting Standards for Preclinical Studies of Stroke Therapy","volume":"47","author":"Vahidy","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2021.103291_bib0144","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.eplepsyres.2016.11.010","article-title":"Common data elements and data management: remedy to cure underpowered preclinical studies","volume":"129","author":"Lapinlampi","year":"2017","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SHK.0000000000001212","article-title":"Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis","volume":"50","author":"Osuchowski","year":"2018","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0146","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/neu.2015.4113","article-title":"Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium for acute therapies in severe traumatic brain injury: operation brain trauma therapy","volume":"33","author":"Kochanek","year":"2016","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003693","article-title":"Reproducibility of preclinical animal research improves with heterogeneity of study samples","volume":"16","author":"Voelkl","year":"2018","journal-title":"PLoS Biol"},{"issue":"38","key":"10.1016\/j.ebiom.2021.103291_bib0148","doi-asserted-by":"crossref","first-page":"23652","DOI":"10.1073\/pnas.2008281117","article-title":"A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants","volume":"117","author":"Dearlove","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2021.103291_bib0149","doi-asserted-by":"crossref","unstructured":"Kemp SA, Collier DA, Datir R, Ferreira I, Gayed S, Jahun A, Hosmillo M, Rees-Spear C, Mlcochova P, Lumb IU et\u00a0al. Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation. https:\/\/wwwbiorixorg 2021.","DOI":"10.1101\/2020.12.05.20241927"},{"key":"10.1016\/j.ebiom.2021.103291_bib0150","doi-asserted-by":"crossref","unstructured":"Kemp S, Meng B, Ferriera I, Datir R, Harvey W, Collier D, Lytras S, Papa G, Carabelli A, Kenyon J et\u00a0al. PREPRINT: Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion H69\/V70. https:\/\/wwwbiorixorg 2021.","DOI":"10.2139\/ssrn.3780277"},{"key":"10.1016\/j.ebiom.2021.103291_bib0151","doi-asserted-by":"crossref","unstructured":"Nelson G, Buzko O, Spilman P, Niazi K, Rabizadeh S, Soon-Shiong P. PREPRINT: Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant. https:\/\/wwwbiorixorg 2021.","DOI":"10.1101\/2021.01.13.426558"},{"key":"10.1016\/j.ebiom.2021.103291_bib0152","doi-asserted-by":"crossref","unstructured":"Voloch C, da Silva F Jr R, de Almeida L, Cardoso C, Brustolini O, Gerber A, de C Guimar\u00e3es A, Mariani D, da Costa R, Ferreira Jr O et\u00a0al. PREPRINT: Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. https:\/\/wwwbiorixorg 2021.","DOI":"10.1101\/2020.12.23.20248598"},{"issue":"6523","key":"10.1016\/j.ebiom.2021.103291_bib0153","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo","volume":"370","author":"Hou","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103291_bib0154","article-title":"SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility","author":"Zhou","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2021.103291_bib0155","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","author":"Plante","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0156","article-title":"Establishment of an African green monkey model for COVID-19","author":"Woolsey","year":"2020","journal-title":"bioRxiv"},{"issue":"6505","key":"10.1016\/j.ebiom.2021.103291_bib0157","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"issue":"6505","key":"10.1016\/j.ebiom.2021.103291_bib0158","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246366","article-title":"Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure","volume":"16","author":"Johnston","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2021.103291_bib0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2020.12.013","article-title":"Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques","volume":"554","author":"Ishigaki","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2021.103291_bib0161","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virol.2020.07.015","article-title":"Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"550","author":"Dobrovolny","year":"2020","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0162","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41422-020-00450-0","article-title":"Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res"},{"issue":"7830","key":"10.1016\/j.ebiom.2021.103291_bib0163","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0164","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/s41467-020-18077-5","article-title":"An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques","volume":"11","author":"Feng","year":"2020","journal-title":"Nat Commun"},{"issue":"7845","key":"10.1016\/j.ebiom.2021.103291_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41586-020-3035-9","article-title":"A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"590","author":"Sanchez-Felipe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0166","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03275-y","article-title":"Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0167","first-page":"1","article-title":"A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in Rhesus Macaques","author":"Li","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2021.103291_bib0168","article-title":"Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates","author":"Mukhopadhyay","year":"2020","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0169","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.chom.2020.11.012","article-title":"D614G spike mutation increases SARS CoV-2 susceptibility to neutralization","volume":"29","author":"Weissman","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103291_bib0171","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"issue":"50","key":"10.1016\/j.ebiom.2021.103291_bib0172","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","article-title":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge","volume":"38","author":"Guebre-Xabier","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0173","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/22221751.2020.1821583","article-title":"SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0174","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41467-020-20602-5","article-title":"A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"issue":"7819","key":"10.1016\/j.ebiom.2021.103291_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0176","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103291_bib0177","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41541-020-00246-8","article-title":"Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein","volume":"5","author":"McAuley","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0178","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cmi.2020.07.020","article-title":"Viable SARS-CoV-2 in various specimens from COVID-19 patients","volume":"26","author":"Jeong","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103291_bib0179","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103291_bib0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","author":"Cox","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2021.103291_bib0181","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103153","article-title":"Prophylactic intranasal administration of a TLR2\/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model","volume":"63","author":"Proud","year":"2021","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103291_bib0182","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103291_bib0183","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/cid\/ciaa644","article-title":"Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7818","key":"10.1016\/j.ebiom.2021.103291_bib0184","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0185","article-title":"SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model","author":"Bertzbach","year":"2020","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103291_bib0186","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.09.007","article-title":"High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models","volume":"183","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103291_bib0187","article-title":"Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103291_bib0188","article-title":"Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals","author":"Wernike","year":"2020","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.ebiom.2021.103291_bib0189","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo","author":"Hou","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0190","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41591-020-1070-6","article-title":"Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters","volume":"26","author":"Tostanoski","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103291_bib0191","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo","volume":"218","author":"Schafer","year":"2021","journal-title":"J Exp Med"},{"issue":"47","key":"10.1016\/j.ebiom.2021.103291_bib0192","doi-asserted-by":"crossref","first-page":"29832","DOI":"10.1073\/pnas.2010197117","article-title":"Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6520","key":"10.1016\/j.ebiom.2021.103291_bib0193","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0194","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A Therapeutic Non-self-reactive SARS-CoV-2 Antibody protects from lung pathology in a COVID-19 hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103291_bib0195","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","article-title":"Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy","volume":"183","author":"Du","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103291_bib0196","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41564-020-00802-x","article-title":"Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters","volume":"5","author":"Yuan","year":"2020","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0197","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-020-00279-z","article-title":"Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters","volume":"6","author":"Brocato","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2021.103291_bib0198","article-title":"The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro","volume":"183","author":"Song","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0199","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"issue":"7831","key":"10.1016\/j.ebiom.2021.103291_bib0200","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-020-2334-5","article-title":"Infection of dogs with SARS-CoV-2","volume":"586","author":"Sit","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103291_bib0201","article-title":"Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat and hamster sera","author":"Perera","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103291_bib0202","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41467-020-19891-7","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice","volume":"11","author":"Oladunni","year":"2020","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103291_bib0203","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142032","article-title":"Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease","volume":"5","author":"Golden","year":"2020","journal-title":"JCI Insight"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:06:10Z","timestamp":1762455970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":203,"alternative-id":["S2352396421000840"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103291","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103291"}}